140 related articles for article (PubMed ID: 14576821)
1. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1.
Gupta A; Inaba S; Wong OK; Fang G; Liu J
Oncogene; 2003 Oct; 22(48):7593-9. PubMed ID: 14576821
[TBL] [Abstract][Full Text] [Related]
2. Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells.
Inaba S; Li C; Shi YE; Song DQ; Jiang JD; Liu J
Breast Cancer Res Treat; 2005 Nov; 94(1):25-35. PubMed ID: 16142440
[TBL] [Abstract][Full Text] [Related]
3. p55CDC/hCDC20 is associated with BUBR1 and may be a downstream target of the spindle checkpoint kinase.
Wu H; Lan Z; Li W; Wu S; Weinstein J; Sakamoto KM; Dai W
Oncogene; 2000 Sep; 19(40):4557-62. PubMed ID: 11030144
[TBL] [Abstract][Full Text] [Related]
4. Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs.
Singh VK; Zhou Y; Marsh JA; Uversky VN; Forman-Kay JD; Liu J; Jia Z
Cancer Res; 2007 Jan; 67(2):626-33. PubMed ID: 17234772
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
6. The mitotic checkpoint gene BubR1 has two distinct functions in mitosis.
Harris L; Davenport J; Neale G; Goorha R
Exp Cell Res; 2005 Aug; 308(1):85-100. PubMed ID: 15907836
[TBL] [Abstract][Full Text] [Related]
7. BUBR1 phosphorylation is regulated during mitotic checkpoint activation.
Li W; Lan Z; Wu H; Wu S; Meadows J; Chen J; Zhu V; Dai W
Cell Growth Differ; 1999 Nov; 10(11):769-75. PubMed ID: 10593653
[TBL] [Abstract][Full Text] [Related]
8. p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation.
Ha GH; Baek KH; Kim HS; Jeong SJ; Kim CM; McKeon F; Lee CW
Cancer Res; 2007 Aug; 67(15):7155-64. PubMed ID: 17671183
[TBL] [Abstract][Full Text] [Related]
9. BubR1 is required for a sustained mitotic spindle checkpoint arrest in human cancer cells treated with tubulin-targeting pyrrolo-1,5-benzoxazepines.
Greene LM; Campiani G; Lawler M; Williams DC; Zisterer DM
Mol Pharmacol; 2008 Feb; 73(2):419-30. PubMed ID: 17991869
[TBL] [Abstract][Full Text] [Related]
10. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.
Fu Y; Ye D; Chen H; Lu W; Ye F; Xie X
Gynecol Oncol; 2007 Apr; 105(1):66-73. PubMed ID: 17234259
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
[TBL] [Abstract][Full Text] [Related]
12. Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1.
Futamura M; Arakawa H; Matsuda K; Katagiri T; Saji S; Miki Y; Nakamura Y
Cancer Res; 2000 Mar; 60(6):1531-5. PubMed ID: 10749118
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences.
Lu A; Gupta A; Li C; Ahlborn TE; Ma Y; Shi EY; Liu J
Oncogene; 2001 Aug; 20(37):5173-85. PubMed ID: 11526506
[TBL] [Abstract][Full Text] [Related]
14. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
[TBL] [Abstract][Full Text] [Related]
15. Spindle checkpoint function requires Mad2-dependent Cdc20 binding to the Mad3 homology domain of BubR1.
Davenport J; Harris LD; Goorha R
Exp Cell Res; 2006 Jun; 312(10):1831-42. PubMed ID: 16600213
[TBL] [Abstract][Full Text] [Related]
16. Identification and purification of a soluble region of BubR1: a critical component of the mitotic checkpoint complex.
Yoon J; Kang Y; Kim K; Park J; Kim Y
Protein Expr Purif; 2005 Nov; 44(1):1-9. PubMed ID: 15946858
[TBL] [Abstract][Full Text] [Related]
17. BCSG1 methylation status and BCSG1 expression in breast tissues derived from Chinese women with breast cancer.
Gu YM; Tan JX; Lu XW; Ding Y; Han X; Sun YJ
Oncology; 2008; 74(1-2):61-8. PubMed ID: 18544996
[TBL] [Abstract][Full Text] [Related]
18. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.
Ji H; Liu YE; Jia T; Wang M; Liu J; Xiao G; Joseph BK; Rosen C; Shi YE
Cancer Res; 1997 Feb; 57(4):759-64. PubMed ID: 9044857
[TBL] [Abstract][Full Text] [Related]
19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
20. [The effect of breast cancer specific gene 1 in the prognosis of breast cancer].
Wu KJ; Weng ZY; Lin GF; Wu XR; Li FM; Zhang YC
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):294-7. PubMed ID: 15842935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]